A Plus Biotechnology Co

A Plus Biotechnology Co EBIT per Share

The EBIT per Share of A Plus Biotechnology Co (6918.TWO) as of Oct 17, 2026 is 6.01 TWD. In the previous year, EBIT per Share was 5.53 TWD — a change of 8.69% (higher).

EBIT per Share

6.01TWD

YoY

8.69%

Last updated:

EBIT per Share of A Plus Biotechnology Co is 2024 6.01 TWD. EBIT per Share of A Plus Biotechnology Co was 2023 5.53 TWD. It decreases by 8.69% higher compared to the previous year.

The A Plus Biotechnology Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
1.37 TWD
Jan 1, 2020
1.40 TWD
Jan 1, 2021
1.53 TWD
Jan 1, 2022
2.19 TWD
Jan 1, 2023
5.53 TWD
Jan 1, 2024
6.01 TWD
The A Plus Biotechnology Co EBIT per Share history
YEAREBIT per ShareYoY
6.01TWD+8.69%
5.53TWD+152.16%
2.19TWD+42.93%
1.53TWD+9.91%
1.40TWD+1.86%
1.37TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

A Plus Biotechnology Co Stock analysis

What does A Plus Biotechnology Co do? A Plus Biotechnology Co Ltd, listed on the Taiwan Stock Exchange with ticker 6918.TWO, operates in the Health Care sector. The company is based in Taipei, Taiwan, and focuses on research, development, and manufacturing of orthopedic medical equipment. Its product portfolio includes trauma products for fracture fixation, orthopedic correction systems, artificial bone replacements, and spinal fixation devices. The company went public on January 6, 2023. Products are sold domestically and exported to mainland China, Asia, the United States, and Africa. A Plus Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about A Plus Biotechnology Co stock

EBIT per Share of A Plus Biotechnology Co is 6.01 TWD in 2024.

EBIT per Share of A Plus Biotechnology Co changed from 5.53 TWD to 6.01 TWD, representing a 8.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share A Plus Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — A Plus Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — A Plus Biotechnology Co